Pros and Cons of Skeletal Medications in the COVID-19 Era.

Published in: Current treatment options in rheumatology (2022)

The impact of the COVID-19 pandemic on long-term bone health remains unknown but focused interventions to ensure osteoporosis treatment initiation/maintenance should be implemented. Future studies are needed to determine whether osteoporosis medications have an impact on SARS-CoV-2 pathophysiology and COVID-19 clinical outcomes.

Keyphrases

sars cov
bone mineral density
postmenopausal women
coronavirus disease
respiratory syndrome coronavirus
public health
healthcare
mental health
body composition
physical activity
combination therapy
risk assessment
soft tissue
case control
social media
smoking cessation